Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $3.5 million.

  • Xtant Medical Holdings' Net Cash Flow rose 12180.21% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year increase of 31182.35%. This contributed to the annual value of $447000.0 for FY2024, which is 10306.0% up from last year.
  • According to the latest figures from Q3 2025, Xtant Medical Holdings' Net Cash Flow is $3.5 million, which was up 12180.21% from $1.6 million recorded in Q2 2025.
  • Xtant Medical Holdings' Net Cash Flow's 5-year high stood at $16.3 million during Q1 2021, with a 5-year trough of -$15.1 million in Q1 2023.
  • Over the past 5 years, Xtant Medical Holdings' median Net Cash Flow value was -$124000.0 (recorded in 2022), while the average stood at $440105.3.
  • In the last 5 years, Xtant Medical Holdings' Net Cash Flow surged by 137929.52% in 2022 and then tumbled by 96617.23% in 2023.
  • Quarter analysis of 5 years shows Xtant Medical Holdings' Net Cash Flow stood at -$227000.0 in 2021, then skyrocketed by 1379.3% to $2.9 million in 2022, then crashed by 199.97% to -$2.9 million in 2023, then soared by 73.96% to -$756000.0 in 2024, then soared by 565.61% to $3.5 million in 2025.
  • Its Net Cash Flow was $3.5 million in Q3 2025, compared to $1.6 million in Q2 2025 and -$784000.0 in Q1 2025.